libera/##covid-19/ Friday, 2024-11-22

de-factohttps://www.ema.europa.eu/en/medicines/human/EPAR/lagevrio   On 21 June 2023, Merck Sharp & Dohme B.V. withdrew its application for a marketing authorisation of Lagevrio for the treatment of COVID-19 in adults.00:02
LjLde-facto, is/was that the only molnupiravir available in europe?00:09
de-factoLjL, not sure but i guess a Corp would aim at exclusive rights on their investment00:22
LjLde-facto, i just didn't even remember whether or not molnupiravir was approved at all in the EU00:31
LjLi just lose track of things00:31
de-factonot sure how widespread it was used, apparently it was in CZ though00:35
BrainstormNew from The Lancet (Online): [Articles] Ten Americas: a systematic analysis of life expectancy disparities in the USA: Our analysis confirms the continued existence of different Americas within the USA. One's life expectancy varies dramatically depending on where one lives, the economic [... want %more?] → https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01495-8/fulltext00:35
de-facto"In October 2021, the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) started a rolling review of molnupiravir.[44] In February 2023, the EMA recommended the refusal of the marketing authorization for molnupiravir.[45] In June 2023, Merck Sharp & Dohme withdrew its application for a marketing authorization of molnupiravir."01:30
de-facto%title https://en.wikipedia.org/wiki/Molnupiravir01:30
Brainstormde-facto: From en.wikipedia.org: Molnupiravir - Wikipedia01:30
BrainstormNew from Virology.ws: Trial By Error: Interview with Karen Hargrave, Co-Founder of #ThereForME: By David Tuller, DrPH Karen Hargrave is co-founder of an advocacy campaign called #ThereForME, which was launched this past summer to draw public awareness to the UK’s lack of [... want %more?] → https://virology.ws/2024/11/21/trial-by-error-interview-with-karen-hargrave-co-founder-of-thereforme/04:29
BrainstormNew from r/COVID19: COVID19: The impact of vaccination on preventing long COVID in the Omicron era: a systematic review and meta-analysis → https://old.reddit.com/r/COVID19/comments/1gwzemg/the_impact_of_vaccination_on_preventing_long/05:27
BrainstormNew from BMJ Open: Pulmonary complications and mortality among COVID-19 patients undergoing a surgery: a multicentre cohort study: Objectives Our primary objective was to assess the association between symptoms at the time of surgery and postoperative pulmonary complications and mortality in patients with COVID-19. Our [... want %more?] → http://bmjopen.bmj.com/cgi/content/short/14/11/e09015808:01
BrainstormNew from Science-Based Medicine: Laptop Class Doctors Think Doctors Who Treat Patients Are Lazy, Dumb, Cowardly, Sheep: Had laptop class doctors been willing to listen to doctors who worked on COVID units, they wouldn't have said so many absurd things. The post  first appeared on Science-Based Medicine . → https://sciencebasedmedicine.org/laptopdoctors/09:09
BrainstormNew from StatNews: First Opinion: Opinion: I’m a vaccine activist — and I’m optimistic about the future right now → https://www.statnews.com/2024/11/22/vaccine-advocacy-safe-communities-coalition-rfk-jr/10:37
BrainstormNew from r/Science: science: New malaria vaccine is delivered by a mosquito bite - Bites from insects infected with modified malaria parasites boosted immunity and stopped nearly 90% people from contracting the disease in human trials. The two current malaria vaccines are only [... want %more?] → https://old.reddit.com/r/science/comments/1gx4uf5/new_malaria_vaccine_is_delivered_by_a_mosquito/11:55
BrainstormNew from PubMed: Efficacy and safety of Toliparibumab for the treatment of non-small cell lung cancer: a systematic review and meta-analysis: CONCLUSIONS: Toripalimab, being China's first domestically developed anti-tumor PD-1 antibody drug, shows potential advantages over traditional chemotherapy in possibly prolonging patients' [... want %more?] → https://pubmed.ncbi.nlm.nih.gov/39575424/12:25
BrainstormNew from Reddit (test): CoronavirusUK: Survey on your experience of pregnancy (18+; ~12 mins to complete; Pregnant participants or people with pregnant partners only; £100 Amazon voucher raffle) → https://old.reddit.com/r/CoronavirusUK/comments/1gx5ggf/survey_on_your_experience_of_pregnancy_18_12_mins/12:55
BrainstormNew from Reddit (test): CoronavirusUK: Exploring Factors Associated with COVID-19 Vaccine Decision Making Hi all, I am currently completing my doctoral thesis looking at how our thinking styles impact decision making about Covid-19 Vaccines. If you are over 18 years [... want %more?] → https://old.reddit.com/r/CoronavirusUK/comments/1gx7iop/exploring_factors_associated_with_covid19_vaccine/14:26
BrainstormNew from Contagion Live: One Health, One Mission: Combatting AMR During US Antibiotic Awareness Week 2024: Along with the CDC, we highlight the One Health approach and advocate for effective infection control measures, such as vaccination and innovative [... want %more?] → https://www.contagionlive.com/view/one-health-one-mission-combatting-amr-during-us-antibiotic-awareness-week-202414:55
BrainstormNew from Reddit (test): COVID19_Pandemic: Mike Hoerger: "Did anyone notice that the CDC just modified their dashboard to make Covid transmission look lower? The underlying data are identical. However, the Y axis is rescaled to make everything seem lower." → https://old.reddit.com/r/COVID19_Pandemic/comments/1gx8awp/mike_hoerger_did_anyone_notice_that_the_cdc_just/15:05
BrainstormNew from ECDC: Weekly respiratory virus update, week 46, November 2024: In EU/EEA countries, a sharp increase was observed in respiratory syncytial virus activity, marking the start of the epidemic wave. Influenza and SARS-CoV-2 activities remained at relatively low levels. → https://www.ecdc.europa.eu/en/publications-data/weekly-respiratory-virus-update-week-46-november-202416:15
BrainstormNew from EMA: What's new: (news): Human medicines European public assessment report (EPAR): M-M-RVaxPro, measles, mumps and rubella vaccine (live), Date of authorisation: 05/05/2006, Revision: 33, Status: Authorised → https://www.ema.europa.eu/en/medicines/human/EPAR/m-m-rvaxpro16:45
BrainstormNew from ECDC: Communicable disease threats report, 16-22 November 2024, week 47: The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue of the CDTR covers [... want %more?] → https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-16-22-november-2024-week-4717:04
BrainstormNew from BMJ: Does NICE’s “severity modifier” for assessing diseases need to change?: What is Enhertu?Trastuzumab deruxtecan (Enhertu), made by Daiichi Sankyo and AstraZeneca, is a treatment for adult patients with unresectable or metastatic HER2 low breast cancer who have received previous chemotherapy in the metastatic [... want %more?] → http://www.bmj.com/content/387/bmj.q2620.short18:52
BrainstormNew from Marc Veldhoen on Mastodon: (news): To summarise: Geert Vanden Bossche is an anti-vaxxer who has no clue about the evolutionary dynamics of this pandemic, and how vaccines or the immune system works. However, he probably made a good-amount of money with appearances in the anti-vax circuit. → https://mastodon.online/@marc_veld/11352793772124603419:12
BrainstormNew from Contagion Live: Respiratory Vaccines Update: Robert H. Hopkins, Jr., MD, medical director, National Foundation for Infectious Diseases (NFID) and ACIP liaison offers guidance and insights on a variety of respiratory vaccines. → https://www.contagionlive.com/view/respiratory-vaccines-update20:00
BrainstormNew from r/Science: science: Younger and middle-aged adults have worse long COVID symptoms than older adults. Symptoms included headache, problems with smell and taste, depression, anxiety, insomnia, fatigue and a decrease in cognitive function. They occurred regardless of if [... want %more?] → https://old.reddit.com/r/science/comments/1gxfau6/younger_and_middleaged_adults_have_worse_long/20:10
BrainstormNew from StatNews: Health: STAT+: Rand Paul plans to investigate Covid-19 origins from his new perch leading a key committee → https://www.statnews.com/2024/11/22/rand-paul-senate-investigation-covid-19-origin-lab-leak-theory-anthony-fauci-nih/20:39
BrainstormNew from CIDRAP: US respiratory virus activity remains low ahead of holiday season: With flu and COVID levels still low but expected to rise, the CDC said vaccination is a good way to cut risk over the holiday season. → https://www.cidrap.umn.edu/influenza-general/us-respiratory-virus-activity-remains-low-ahead-holiday-season21:56
BrainstormNew from CIDRAP: Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes: By November 9, 35% of adults reported having received the flu vaccine and 18% the updated COVID-19 vaccine, and 40% of those aged 75 years and older had ever [... want %more?] → https://www.cidrap.umn.edu/influenza-vaccines/very-few-us-adults-getting-new-flu-covid-rsv-vaccines-even-nursing-homes22:16
BrainstormNew from StatNews: STAT+: Sanofi plans to change payment terms for 340B hospitals: Sanofi is the third company - along with J&J and Eli Lilly - to attempt to change the way it pays for medicines under the 340B program. → https://www.statnews.com/pharmalot/2024/11/22/340b-hospitals-sanofi-jnj-lilly-medicines-drugs-discounts/22:54

Generated by irclog2html.py 2.17.0 by Marius Gedminas - find it at https://mg.pov.lt/irclog2html/!